phenylalanine and Coronary Artery Disease

phenylalanine has been researched along with Coronary Artery Disease in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (38.46)29.6817
2010's6 (46.15)24.3611
2020's2 (15.38)2.80

Authors

AuthorsStudies
Emamgholipour, S; Hosseinkhani, S; Khalagi, K; Larijani, B; Najjar, N; Pasalar, P; Razi, F; Salari, P; Shirani, S1
Aoyagi, R; Arita, M; Furuno, K; Hamase, K; Hara, T; Hirono, K; Kobayashi, T; Miyamoto, T; Mizuno, Y; Nakashima, Y; Nishio, H; Ohga, S; Onouchi, Y; Sakai, Y; Suzuki, H; Takada, H; Takatsuki, S; Tanabe, K; Tanaka, T; Yamamura, K1
Kim, SS; Koide, M; Nagasawa, Y; Sawada, T; Shiotani, H; Terashita, D; Yokoyama, M1
Kataoka, Y; Kimura, K; Kosuge, M; Miyamoto, Y; Miyazaki, S; Sase, K; Yasuda, S; Yoshimasa, Y2
DeFronzo, RA; Ferrannini, E1
Cahyaningtyas, M; Masbuchin, AN; Putri, JF; Rohman, MS1
Masuzaki, H; Sata, M; Shimabukuro, M1
Karikas, GA; Papakonstantinou, E; Schulpis, KH1
Araujo, CM; Cristóvão, SA; Mangione, JA; Mauro, MF; Oliveira Neto, JB; Rando, GA; Salman, AA; Sanchez, IS1
Eftekhari, H; Hajilooi, M; Massoud, A; Sanati, A; Tajik, N1
Choi, JB; Hirose, T; Kawamori, R; Mita, T; Sato, F; Shimizu, T; Tamura, Y; Tanaka, Y; Watada, H; Watanabe, T1
Brown, G; Castro, E; Deeb, SS; Edland, SD; Erkkola, R; Lee, L; Louhija, J; Martin, GM; Ogburn, CE; Oshima, J; Panduro, A; Penttinen, R; Riestra, R; Tilvis, R; Wang, L1

Reviews

1 review(s) available for phenylalanine and Coronary Artery Disease

ArticleYear
Impact of glucose-lowering drugs on cardiovascular disease in type 2 diabetes.
    European heart journal, 2015, Sep-07, Volume: 36, Issue:34

    Topics: Carbamates; Clinical Trials as Topic; Coronary Artery Disease; Cyclohexanes; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Dipeptidyl-Peptidase IV Inhibitors; Glucagon-Like Peptide-1 Receptor; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Insulin; Metformin; Nateglinide; Phenylalanine; Piperidines; Sodium-Glucose Transport Proteins; Sulfonylurea Compounds; Thiazolidinediones; Treatment Outcome

2015

Trials

3 trial(s) available for phenylalanine and Coronary Artery Disease

ArticleYear
Comparison of effects of α-Glucosidase inhibitors and glinide drugs on endothelial dysfunction in diabetic patients with coronary artery disease.
    Circulation journal : official journal of the Japanese Circulation Society, 2014, Volume: 78, Issue:1

    Topics: 1-Deoxynojirimycin; Aged; Aged, 80 and over; Coronary Artery Disease; Cyclohexanes; Diabetic Angiopathies; Dyslipidemias; Endothelium, Vascular; Enzyme Inhibitors; Female; Glycoside Hydrolase Inhibitors; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin Resistance; Lipids; Male; Middle Aged; Nateglinide; Phenylalanine

2014
Effects of voglibose and nateglinide on glycemic status and coronary atherosclerosis in early-stage diabetic patients.
    Circulation journal : official journal of the Japanese Circulation Society, 2012, Volume: 76, Issue:3

    Topics: Aged; Coronary Artery Disease; Cyclohexanes; Diabetes Complications; Diabetes Mellitus; Female; Glycemic Index; Humans; Hypoglycemic Agents; Inositol; Male; Middle Aged; Nateglinide; Phenylalanine

2012
Nateglinide reduces carotid intima-media thickening in type 2 diabetic patients under good glycemic control.
    Arteriosclerosis, thrombosis, and vascular biology, 2007, Volume: 27, Issue:11

    Topics: Aged; Blood Glucose; Carotid Arteries; Coronary Artery Disease; Cyclohexanes; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Middle Aged; Nateglinide; Phenylalanine; Tunica Intima; Tunica Media

2007

Other Studies

9 other study(ies) available for phenylalanine and Coronary Artery Disease

ArticleYear
Evaluating the association between amino acid and acylcarnitine profiles and different levels of coronary artery disease risk in postmenopausal women using targeted metabolomics technique.
    Menopause (New York, N.Y.), 2022, 09-01, Volume: 29, Issue:9

    Topics: Amino Acids; Biomarkers; Carnitine; Coronary Angiography; Coronary Artery Disease; Cross-Sectional Studies; Female; Humans; Phenylalanine; Postmenopause; Risk Factors; Vascular Calcification

2022
Lipidomics links oxidized phosphatidylcholines and coronary arteritis in Kawasaki disease.
    Cardiovascular research, 2021, 01-01, Volume: 117, Issue:1

    Topics: Adaptor Proteins, Signal Transducing; Arteritis; Biomarkers; Case-Control Studies; Child; Child, Preschool; Chromatography, Liquid; Coronary Artery Disease; Female; Humans; Japan; Lipidomics; Lipoproteins, LDL; Male; Mucocutaneous Lymph Node Syndrome; Oxidation-Reduction; Phenylalanine; Phosphatidylcholines; Prospective Studies; Scavenger Receptors, Class E; Tandem Mass Spectrometry

2021
Clinical predictors of atheroma progression despite optimal glycemic control in early-stage diabetic patients with coronary artery disease: Insight from the DIANA study.
    Journal of atherosclerosis and thrombosis, 2014, Volume: 21, Issue:5

    Topics: Blood Glucose; Coronary Angiography; Coronary Artery Disease; Cyclohexanes; Diabetes Mellitus; Disease Progression; Double-Blind Method; Female; Follow-Up Studies; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Inositol; Life Style; Male; Middle Aged; Nateglinide; Phenylalanine; Plaque, Atherosclerotic; Prospective Studies; Risk Factors; Ultrasonography, Interventional

2014
279(Val→Phe) Polymorphism of lipoprotein-associated phospholipase A(2) resulted in changes of folding kinetics and recognition to substrate.
    Computational biology and chemistry, 2015, Volume: 59 Pt A

    Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Acute Disease; Case-Control Studies; Computational Biology; Coronary Artery Disease; Genotype; Humans; Kinetics; Male; Middle Aged; Molecular Dynamics Simulation; Phenylalanine; Polymorphism, Genetic; Protein Folding; Software; Substrate Specificity; Valine

2015
Intensive glucose lowering in cardiovascular risk management - unsolved questions - .
    Circulation journal : official journal of the Japanese Circulation Society, 2012, Volume: 76, Issue:3

    Topics: Coronary Artery Disease; Cyclohexanes; Diabetes Mellitus; Female; Glycemic Index; Humans; Inositol; Male; Nateglinide; Phenylalanine

2012
Homocysteine and other vascular risk factors in patients with phenylketonuria on a diet.
    Acta paediatrica (Oslo, Norway : 1992), 2002, Volume: 91, Issue:8

    Topics: Child; Child, Preschool; Coronary Artery Disease; Diet, Protein-Restricted; Endothelin-1; Folic Acid; Homocysteine; Humans; Lipids; Nutrition Assessment; Phenylalanine; Phenylketonurias; Risk Factors; Vitamin B 12; Vitamin B 6

2002
[Batimastat-eluting stent implantation for the treatment of coronary artery disease: results of the Brazilian pilot study].
    Arquivos brasileiros de cardiologia, 2005, Volume: 84, Issue:3

    Topics: Adult; Brazil; Catheterization; Coronary Artery Disease; Coronary Restenosis; Female; Humans; Male; Middle Aged; Phenylalanine; Pilot Projects; Prospective Studies; Protease Inhibitors; Stents; Thiophenes

2005
Association of the Phe206Leu allele of the L-selectin gene with coronary artery disease.
    Cardiology, 2006, Volume: 105, Issue:2

    Topics: Aged; Case-Control Studies; Coronary Artery Disease; Female; Gene Frequency; Humans; Iran; L-Selectin; Leucine; Male; Middle Aged; Mutation, Missense; Phenylalanine

2006
Polymorphisms at the Werner locus: II. 1074Leu/Phe, 1367Cys/Arg, longevity, and atherosclerosis.
    American journal of medical genetics, 2000, Dec-11, Volume: 95, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Aging; Amino Acid Substitution; Arginine; Arteriosclerosis; Coronary Artery Disease; Cysteine; Finland; Gene Frequency; Genotype; Haplotypes; Humans; Infant, Newborn; Leucine; Longevity; Mexico; Middle Aged; Phenylalanine; Polymorphism, Genetic; Werner Syndrome

2000